Rare diseases
Investigational molecules
Locations
Study on Imlifidase for Highly Sensitized Patients with End-Stage Chronic Kidney Disease Awaiting Transplant
AustriaStudy on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
AustriaStudy on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases
AustriaStudy on the Safety and Effects of Berotralstat for Children Aged 2 to 12 with Hereditary Angioedema (HAE)
AustriaStudy of Apalutamide for Patients with High-Risk Prostate Cancer After Prostate Removal
AustriaStudy on the Effectiveness of Asciminib and Imatinib for Patients with Chronic Myelogenous Leukemia Not Responding to Imatinib
AustriaStudy of Aflibercept 8mg for Patients with Neovascular Age-Related Macular Degeneration Previously Treated with Faricimab and Aflibercept 2mg
AustriaStudy of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease
AustriaStudy of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients
AustriaLong-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)
AustriaStudy on Enzalutamide and Drug Combination for High-Risk Localized Prostate Cancer Patients
AustriaStudy on the Effectiveness and Safety of Olaparib Alone and with Durvalumab for Patients with Early Stage HER2-Negative Breast Cancer with BRCA Mutations
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
